AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9832936
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg nicotine
Trial: 2838426
Drug: Potassium iodide
RxNorm normalized name: Potassium Iodide
DrugBank: Potassium Iodide (DB06715)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium iodide (0.5 g, 1.0 g, and 2.0 g)
Trial: 31055677
Drug: Visual attention
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Visual attention training (twice a week for 45 min sessions over 3 weeks)
Trial: 26493038
Drug: 5‐monthly fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐monthly fixed dosing of Ozurdex
Trial: 16491463
Drug: Oral polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral polyethylene glycol (PEG) solution (3 litres)
Trial: 11395986
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron supplementation (FeSO4) for 18 weeks
Trial: 9257425
Drug: Sargramostim (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sargramostim (300 micrograms; 193 mg/m2)
Trial: 9257425
Drug: Filgrastim (481
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgrastim (481 mg; 7 mg/kg)
Trial: 3037835
Drug: High-dose ketoconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ketoconazole (400 mg every 8 h)
Trial: 3037835
Drug: High-dose ketoconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ketoconazole (400 mg every 8 h) + Dexamethasone (0.5 mg twice daily)
Trial: 29615172
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with adjunctive mitomycin C
Trial: 19025306
Drug: Somatostatin (SOM,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin (SOM, 250 mg)
Trial: 19025306
Drug: Octreotide (OCT,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (OCT, 50 mg)
Trial: 20087643
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine and behavioral counseling
Trial: 12091996
Drug: Filgrastim treatment
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim treatment
Trial: 12091996
Drug: Regular treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular treatment (without filgrastim)
Trial: 9494305
Drug: Dextropropoxyphene (DPP)
RxNorm normalized name: dextropropoxyphene
DrugBank: Dextropropoxyphene (DB00647)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextropropoxyphene (DPP) 120 mg to 240 mg daily
Trial: 9494305
Drug: Controlled-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release morphine 20 mg daily
Trial: 3141290
Drug: bacampillin 800
RxNorm normalized name: bacampicillin 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bacampillin 800 mg b.i.d. for ten days
Trial: 3141290
Drug: amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin 500 mg t.i.d. for ten days
Trial: 3141290
Drug: amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin 500 mg t.i.d.
Trial: 3141290
Drug: bacampillin 800
RxNorm normalized name: bacampicillin 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bacampillin 800 mg b.i.d.
Trial: 30106834
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Cytology, FISH, and MP
Trial: 30106834
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FISH and MP
Trial: 30128092
Drug: Persian Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Persian Medicine Protocol (intranasal lavender oil, Liquorice Marjoram Tea)
Trial: 30128092
Drug: Classical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classical treatment (systemic and intranasal cortisone)
Trial: 30128092
Drug: Persian Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Persian Medicine Protocol
Trial: 17261560
Drug: Physiotherapy (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy (10 treatments: deep‐friction, pulsed ultrasound, ice, sensory motor training)
Trial: 9543905
Drug: Patient education
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient education intervention (one-on-one education session by a nephrology nurse using a teaching booklet, Osteodystrophy Tool, and medication diary)
Trial: 7509380
Drug: Taxol (paclitaxel)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Taxol (paclitaxel) 250 mg/m2 without G-CSF
Trial: 7509380
Drug: Taxol (paclitaxel)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Taxol (paclitaxel) 300 mg/m2 with G-CSF
Trial: 7509380
Drug: Taxol (paclitaxel)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Taxol (paclitaxel) 250 mg/m2
Trial: 3132962
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment with intracoronary streptokinase
Trial: 18450124
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 2000 microg nebulized budesonide
Trial: 18450124
Drug: Repeated doses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated doses of 4 x 500 microg nebulized budesonide
Trial: 17162433
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no anticoagulant)
Trial: 10426453
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m2 plus doxorubicin 50 mg/m2
Trial: 10426453
Drug: Docetaxel 60
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 60 mg/m2 plus doxorubicin 60 mg/m2
Trial: 8848891
Drug: mivacurium (final
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mivacurium (final dose 70 micrograms kg‐1)
Trial: 354329
Drug: Fluphenazine enanthate
RxNorm normalized name: Fluphenazine Enanthate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine enanthate (high doses, 10-20 times higher than normal)
Trial: 354329
Drug: Fluphenazine enanthate
RxNorm normalized name: Fluphenazine Enanthate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine enanthate (high doses)
Trial: 28636188
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (continued on pressure lowering medication)
Trial: 22101760
Drug: Tocilizumab (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (4 or 8 mg/kg intravenous infusions every 4 weeks for a total of 6 doses)
Trial: 8345382
Drug: Surfactant administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant administration by pump
Trial: 8345382
Drug: Surfactant administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant administration by hand-dosing method
Trial: 24327590
Drug: Pharmacist intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist intervention (medication reconciliation and patient education)
Trial: 18356697
Drug: Nicorandil therapy
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil therapy (15 mg/day; n = 26)
Trial: 9735589
Drug: Nonrandom assignment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonrandom assignment (self-selected treatment)
Trial: 20081798
Drug: Cavinton therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cavinton therapy
Trial: 15564311
Drug: hylan G-F
RxNorm normalized name: hylan G-F 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hylan G-F 20
Trial: 9893736
Drug: Oral L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-arginine (7 g twice daily)
Trial: 8281847
Drug: Erythromycin 250
RxNorm normalized name: erythromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 250 mg four times a day
Trial: 8281847
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg four times a day
Trial: 2525337
Drug: danazol, 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: danazol, 800 mg/day (n = 10)
Trial: 2525337
Drug: danazol, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: danazol, 600 mg/day (n = 8)
Trial: 2525337
Drug: intranasal nafarelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intranasal nafarelin acetate, 800 micrograms/day (n = 10)
Trial: 2525337
Drug: intranasal nafarelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intranasal nafarelin acetate, 400 micrograms/day (n = 25)
Trial: 25807927
Drug: Hydromorphone immediate-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone immediate-release (IR) tablets
Trial: 25807927
Drug: Hydromorphone extended-release
RxNorm normalized name: hydromorphone Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone extended-release (ER) tablets
Trial: 25807927
Drug: Hydromorphone IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone IR and ER tablets (fed condition)
Trial: 25807927
Drug: Hydromorphone tablets
RxNorm normalized name: hydromorphone Oral Tablet
DrugBank: Hydromorphone (DB00327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydromorphone tablets (both IR and ER)
Trial: 24048387
Drug: Citalopram 40
RxNorm normalized name: citalopram 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 40 mg/day plus quetiapine 300 to 600 mg/day
Trial: 24048387
Drug: Citalopram 40
RxNorm normalized name: citalopram 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 40 mg/day plus placebo
Trial: 21822077
Drug: Midazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.5 mg/kg) and Hydroxyzine (1 mg/kg)
Trial: 17896496
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: Parol and written notice about the content of root canal treatment
Trial: 15472200
Drug: Atorvastatin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin treatment for 16 weeks
Trial: 7993812
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow transplantation (ABMT) with involved marrow infusion
Trial: 2917115
Drug: extradural 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: extradural 0.5% bupivacaine hydrochloride 0.75 mg kg‐1
Trial: 2917115
Drug: extradural 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: extradural 0.1% methadone hydrochloride 4 mg after bupivacaine
Trial: 2917115
Drug: continuous extradural
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: continuous extradural infusion of methadone 0.3 mg h‐1 after operation
Trial: 4584150
Drug: THC 3
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 3 μg/kg
Trial: 4584150
Drug: THC 6
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 6 μg/kg
Trial: 4584150
Drug: THC 9
RxNorm normalized name: delta-9-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 9 μg/kg
Trial: 4584150
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 μg/kg THC)
Trial: 4584150
Drug: THC doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC doses (3, 6, 9 μg/kg)
Trial: 15821181
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2 g/d)
Trial: 15009708
Drug: Ultraviolet-radiation (UVR)
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultraviolet-radiation (UVR) exposure at 1 minimal erythema dose (MED)
Trial: 3526790
Drug: Physostigmine salicylate
RxNorm normalized name: PHYSOSTIGMINE SALICYLATE
DrugBank: Physostigmine (DB00981)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine salicylate 2 mg
Trial: 3526790
Drug: Pethidine chloride
RxNorm normalized name: CHLORIDE
DrugBank: Chloride ion (DB14547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine chloride 50 mg
Trial: 29935544
Drug: Baicalin 500
RxNorm normalized name: BAICALIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baicalin 500 mg orally every day for 12 weeks
Trial: 2540392
Drug: Combination (C)
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (C)
Trial: 9685512
Drug: Alendronate 5
RxNorm normalized name: ALENDRONATE 5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 5 mg/day
Trial: 7041039
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E treatment
Trial: 7600430
Drug: No vitamin
RxNorm normalized name: Vitamin B12 NOS
DrugBank: Cyanocobalamin (DB00115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No vitamin E treatment
Trial: 1292438
Drug: Psychiatric treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychiatric treatment (PT)
Trial: 9199724
Drug: Multimodal behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal behavioural therapy (MBT)
Trial: 6442711
Drug: Auranofin 6
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin 6 mg daily and placebo injection
Trial: 6442711
Drug: Sodium aurothiomalate
RxNorm normalized name: Sodium aurothiomalate
DrugBank: Sodium aurothiomalate (DB09276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium aurothiomalate 50 mg monthly and placebo tablets
Trial: 6442711
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Auranofin and Sodium aurothiomalate)
Trial: 29848769
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin or warfarin
Trial: 27695980
Drug: Mental fatigue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mental fatigue plus caffeine ingestion (5 mg/kg) (MF-CAF)
Trial: 25894953
Drug: Adjunctive edivoxetine
RxNorm normalized name: Edivoxetine
DrugBank: Edivoxetine (DB09184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive edivoxetine (12-18 mg/day)
Trial: 24995890
Drug: Adjunctive edivoxetine
RxNorm normalized name: Edivoxetine
DrugBank: Edivoxetine (DB09184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive edivoxetine
Trial: 18796622
Drug: DPP intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPP intervention groups (placebo, lifestyle, metformin)
Trial: 16816561
Drug: Antibiotics (metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (metronidazole plus erythromycin antenatally and metronidazole plus ampicillin intrapartum)
Trial: 2523645
Drug: Isradipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (2.5 mg or 5 mg twice daily)
Trial: 356497
Drug: Hydrochlorothiazide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (25 mg) and Triamterene (50 mg) with possible addition of Methyldopa (up to 2 g daily)
Trial: 31848551
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein (40 g daily)
Trial: 31848551
Drug: Casein protein
RxNorm normalized name: caseins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein protein (40 g daily)
Trial: 28711736
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose psilocybin (0.160 mg/kg)
Trial: 28711736
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose psilocybin (0.215 mg/kg)
Trial: 28711736
Drug: Psilocybin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin (both doses)
Trial: 23596237
Drug: Antituberculosis agents
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antituberculosis agents
Trial: 18310963
Drug: Interferon-beta (dose:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-beta (dose: 6 MU, daily for 4, 6, or 8 weeks)
Trial: 14680546
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg/day (n = 7)
Trial: 14680546
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100 mg/day (n = 8)
Trial: 11110233
Drug: Tazarotene 0.1%
RxNorm normalized name: TAZAROTENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily
Trial: 11110233
Drug: Calcipotriene 0.005%
RxNorm normalized name: CALCIPOTRIENE 0.005% OINT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriene 0.005% ointment twice daily
Trial: 8642525
Drug: 5% hypertonic
RxNorm normalized name: Walgreens Sodium Chloride 5% Hypertonicity Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% hypertonic saline solution
Trial: 8366876
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg saperconazole per day for 7 days
Trial: 8366876
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg saperconazole per day for 7 days
Trial: 8366876
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg saperconazole per day for 14 days
Trial: 2889281
Drug: 6-month regimen
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month regimen of daily isoniazid plus rifampicin, supplemented by streptomycin twice a week for the first 6 months
Trial: 2889281
Drug: 9-month regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9-month regimen of daily isoniazid plus rifampicin, supplemented by streptomycin twice a week for the first 6 months
Trial: 28729014
Drug: Oral phenazopyridine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral phenazopyridine
Trial: 22525443
Drug: Multiple micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrient supplementation (MMS) given at twice the recommended dietary allowance (RDA)
Trial: 22525443
Drug: Six-multivitamin (MV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six-multivitamin (MV) supplement given in one RDA as the 'standard of care'
Trial: 22525443
Drug: Six-multivitamin (MV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six-multivitamin (MV) supplement
Trial: 21243936
Drug: Sublingual peach
RxNorm normalized name: Peach
DrugBank: Peach (DB10552)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual peach immunotherapy (standardized peach extract quantified in mass units of Pru p 3) for 6 months
Trial: 8934061
Drug: Nomegestrol subdermal
RxNorm normalized name: nomegestrol
DrugBank: Nomegestrol acetate (DB13981)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Nomegestrol subdermal contraceptive implant (Uniplant)
Trial: 1877516
Drug: Caffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated coffee (discontinuation)
Trial: 26493304
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg with morphine 5 mg
Trial: 26493304
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg with placebo
Trial: 24906437
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER (50-250 mg twice daily)
Trial: 24906437
Drug: Morphine SR
RxNorm normalized name: Ratio-Morphine SR
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine SR (20-140 mg/day)
Trial: 22854406
Drug: Pure ß-carotene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure ß-carotene in oil (0.5 mg)
Trial: 22854406
Drug: Golden Rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golden Rice ß-carotene (0.6 mg)
Trial: 22854406
Drug: Spinach ß-carotene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinach ß-carotene (1.4 mg)
Trial: 19736632
Drug: CO2 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CO2 treatment for 18 consecutive days
Trial: 11806476
Drug: Braun Oral-B
RxNorm normalized name: bran Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral-B D17 power toothbrush